• The Journal of the Korean Society for Microbiology
• /
• v.19 no.1
• /
• pp.65-71
• /
• 1984

The author attempted serological typing with the slide agglutination and the production of heat-labile enterotoxin (LT) and heat-stable enterotoxin (ST) by the enterotoxingenic eschenchia coli 446 strains isolated from diarrheal patients. The enterotoxingenic E.coli, producing LT and/or St, were detected by use of assays in the reversed passive hemagglutination(RPHA) and the suckling mouse method. The results obstained were as follows: 1. Of 446 strains isolated, 88 strains(19.73%) produced LT, while 224 strains(50.22%) produced ST, 134(30.05%) produced both LT-ST simultaneously. Serological typing were typed into 06, 08, 020, 025, 027, 0126, 0148 and 0159. Serotype 06 had the highest incidence of 26.46% followed by 0148(18.16%), 027(14.57%); 025(10.99%), 0159(4.03%), 0126(3.59%), 020(1.12%) and 08(0.45%). 2. Serotype 06, 08 and 025 almost always produced both LT and ST, whereas serotypes 020, 027 and 0148 almost always produced only ST. And serotypes 06, 025, 0126 and 0159 almost always produced LT or ST. 3. Of 134 LT-ST positive strains, 115 strains were serotype 06, 3 strains were 025, 2 strains were 08, and 14 strains were 0 untypable. 4. Of 224 ST positive strains, 65 strains were serotype 027, 81 strains were 0148, 16 strains were 0159, and 42 strains were 0 untypable. 5. Of 88 LT positive strains, 45 strains were serotype 025, 5 strains were 0126, 2 strains were 0159, and 42 strains were 0 untypable.

• Clinical and Experimental Reproductive Medicine
• /
• v.20 no.1
• /
• pp.87-94
• /
• 1993

Antiendometrial antibodies were tested by passive hemagglutination assay(PHA) and enzyme linked immunosorbent assay(ELISA) in sera of 45 patients with endometriosis and 21 controls for the evaluation of its clinical usefulness. Both titers(reciprocal) of serum antiendometrial antibody by PHA and ELISA reactivity against endometrial antigens at 405nm were significantly higher in patients with endometriosis than in the control group. Of 45 patients with endometriosis, twenty-six(57.8%) by PHA and twenty-three(51.1%) by ELISA were determined antiendometrial antibody positive but none of the controls were positive. Antiendometrial antibody titers were followed up by PHA and ELISA in 14 patients with high antiendometrial antibody titers before and after treatment with Decapeptyl. There was a decreasing tendency of antiendometrial antibody titers after treatment but there was no statistical significance. These data suggest that the measurement of circulating antiendometrial antibody may be useful for the diagnosis but not for the follow up of endometriosis.

• Pediatric Infection and Vaccine
• /
• v.10 no.2
• /
• pp.153-158
• /
• 2003

Purpose : The incidence of hepatitis B virus infection has gradually decreased since 1983 when hepatitis B vaccine was firstly produced. This study was performed to evaluate the efficacy of hepatitis B immunization. Methods : The elementary, middle and high school children in Incheon area were enrolled in this study in 1997 and 1998. Hepatitis B virus surface antigen(HBsAg) was measured using reversed passive hemagglutination(RPHA). Results : The results were as follows The positive rates of HBsAg in elementary, middle and high school children were 0.7%(337/46,861), 2.5%(381/15,026) and 3.1%(681/21,938) respectively in 1997 and 0.6%(257/41,946), 2.7%(379/13,652) and 2.4%(628/25,277) respectively in 1998. The positive rates of HBsAg in children under 19 years of age in 1985, 1990 and 1995 were 6.1, 5.2 and 3.5% respectively. Conclusion : The positive rates of HBsAg in elementary school children in 1997 and 1998 has decreased compared with those of the previous studies. The majority of elementary school children were given hepatitis B vaccination. These results suggest that hepatitis B vaccines used in Korea were effective for prevention of hepatitis B infection in school children.

• Korean Journal of Poultry Science
• /
• v.34 no.4
• /
• pp.253-257
• /
• 2007

Fayoumi chicks were vaccinated with fowl pox virus vaccine and pigeon pox virus vaccine. The protective potentiality of the two vaccines was compared in field condition in Bangladesh. The percentage of 'take reaction' was assessed to conclude its relationship with better immune response and recorded 93.33% and 100% in birds of group B and group C, respectively. The mean passive hemagglutination (PHA) antibody titre after primary vaccination was $32{\pm}14.81$ in group B and $33{\pm}13.66$ in group C. Following booster vaccination, the mean PHA titres level at pre challenge of group B was $46.93{\pm}16.52\;and\;55.46{\pm}14.64$ in group C. The PHA titre of group B and C at two weeks post challenge recorded $93.86{\pm}33.04\;and\;110.93{\pm}29.29$, respectively. PHA titre significantly (P<0.01) increased after vaccination and post challenge compared to pre- vaccination titre. There was significant variation (p<0.01) of PHA titre at pre challenge in these groups using different vaccine combinations, but all the vaccinated birds resisted challenge infection.

• Journal of Life Science
• /
• v.17 no.6 s.86
• /
• pp.811-815
• /
• 2007

ln this study we isolated 27 isolates of Campylobacter jejuni from stool samples of 882 diarrheal patients. The seasonal distribution of patients was highest at July (11.7%). All the isolates of C. jejuni hydrolyzing sodium hippurate were serotyped on basis of heat-stable antigens, and identified with the use of passive hemagglutination assay. A total of 59.3% among 27 C. jejuni isolates were identified into 6 different serotypes, which serotype HS2, HSl/44, and HS2l were dominant. Antibiotics resistant rates of C. jejuni isolates were shown to be 100%, 63.0%, 51.9%, 37.0%, 33.3%, 25.9% and 7.4% to cephalothin, trimethoprim- sulfamethoxazole, tetracycline, ciprofloxacin, ampicillin, gentamycin and clindamycin, respectively. All isolates were sensitive to the erythromycin and imipenem.

• Pediatric Infection and Vaccine
• /
• v.8 no.2
• /
• pp.213-221
• /
• 2001

Propose : Tsutsugamushi fever is a acute febrile disease, which is caused by O. tsutsugamushi. Recently, this disease is increasingly reported in children. This study was undertaken to investigate clinical features of tsutsugamushi fever in children. Methods : This study involved 17 children with tsutsugamushi fever who were admitted to Masan Samsung hospital between September 1997 and December 2000. We investigated the age, sex ratio, clinical manifestations, laboratory findings, response of therapy and prognosis. Results : The age of patients was $6.9{\pm}3.6$ years, ranging from 6 months to 12 years and male predilection(58.8%) was noted and all cases of patients occured in October or November. The most common symptoms were fever in all cases and headache in 8(47.1%). The most common signs were skin rash in all cases, eschar in 14(82.4%) and lymphadenopathy 8(47.1%). Locations of the eschars were back and inguinal area in each 3 cases, neck and chest in each 2, popliteal area in 2, scalp and thigh in each 1. Laboratory findings included anemia in 1 case, leukopenia and thrombocytopenia in each 5, hematuria and proteinuria in each 1, ESR elevation in 2 and positive CRP in 12, AST elevation in 9 and ALT elevation in 7. Serologic diagnosis was made by passive hemagglutination assay(PHA) in 8 cases(47%) on admission, 4 cases in initial negative group were performed follow-up test at 2nd or 3rd weeks of illness and then all cases of 4 were converted to positive reaction. Clinical improvement was noticed in all cases after treatment to chloramhenicol or doxycycline. Mean duration for defervescence after treatment was $1.4{\pm}0.8$ days. Complications were interstitial pneumonia in 1 case and aseptic meningitis in 3, but all cases of patients were recovered without sequelae or recurrence. Conclusions : Tsutsugamushi fever in children was similiar to adult in the clinical features except male predilection. Early diagnosis and empirical treatment based on clinical manifestations such as fever, skin rash, eschar, lymphadenopathy is important and serologic diagnosis need to perform follow-up test at 2nd or 3rd weeks of illness.